SCHEMBL636837

SCHEMBL636837

O=C(O[C@@H]1C(=O)OC(=O)[C@H]1OC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.48
F2 P00734 1/20 0.48
PPM1B O75688 1/20 0.46
TDP1 Q9NUW8 2/20 0.46
TSHR P16473 2/20 0.45
KMT2A Q03164 4/20 0.44
MAPK1 P28482 1/20 0.44
HIF1A Q16665 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44
CHRNA7 P36544 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 2/20 0.43
ALDH1A1 P00352 1/20 0.43
MEN1 O00255 2/20 0.42
GAA P10253 1/20 0.42
TRPM8 Q7Z2W7 1/20 0.42
HTR3E A5X5Y0 1/20 0.41
HTR3B O95264 1/20 0.41
HTR3A P46098 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL637664 1.00 LMNA (0.48) LMNAF2PPM1BTDP1TSHR
SCHEMBL1751897 1.00 LMNA (0.48) LMNAF2PPM1BTDP1TSHR
SCHEMBL8458023 0.81 TDP1 (0.50) LMNATDP1KMT2ASMN1; SMN2MAPT
SCHEMBL5692175 0.81 TDP1 (0.50) LMNATDP1KMT2ASMN1; SMN2MAPT
SCHEMBL2969544 0.81 TDP1 (0.50) LMNATDP1KMT2ASMN1; SMN2MAPT
SCHEMBL8461105 0.80 PARP1 (0.46) TDP1TSHRKMT2AMAPTALDH1A1
SCHEMBL2244028 0.77 GAA (0.50) LMNAF2TDP1TSHRKMT2A
SCHEMBL8965206 0.77 GAA (0.50) LMNAF2TDP1TSHRKMT2A
SCHEMBL23710673 0.76 MEN1 (0.42) LMNAF2PPM1BKMT2ACHRNA7
SCHEMBL9618911 0.76 BCHE (0.48) KMT2ACHRNA7MAPTMEN1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11370754-B2 Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide CALITHERA BIOSCIENCES, INC. (US) 2022-06-28 US disclosed
US-11370754-B2 Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide CALITHERA BIOSCIENCES, INC. (US) 2022-06-28 US disclosed
US-20210155589-A1 METHOD OF PREPARING (3R,4S)-3-ACETAMIDO-4-ALLYL-N-(TERT-BUTYL)PYRROLIDINE-3-CARBOXAMIDE CALITHERA BIOSCIENCES, INC. (US) 2021-05-27 US disclosed
US-10906872-B2 Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide CALITHERA BIOSCIENCES, INC. (US) 2021-02-02 US disclosed
US-20200087255-A1 METHOD OF PREPARING (3R,4S)-3-ACETAMIDO-4-ALLYL-N-(TERT-BUTYL)PYRROLIDINE-3-CARBOXAMIDE CALITHERA BIOSCIENCES, INC. (US) 2020-03-19 US disclosed
US-10385014-B2 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use ARBOR PHARMACEUTICALS, LLC (US) 2019-08-20 US disclosed
US-20180258032-A1 ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS OF SYNTHESIS AND USE ARBOR PHARMACEUTICALS, LLC 2018-09-13 US disclosed
US-9944592-B2 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use XENOPORT, INC. (US) 2018-04-17 US disclosed
US-20170190657-A1 ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS OF SYNTHESIS AND USE XENOPORT, INC. (US) 2017-07-06 US disclosed
US-9353057-B2 Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof XENOPORT, INC. (US) 2016-05-31 US disclosed
US-20050107334-A1 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use XENOPORT, INC. 2005-05-19 US disclosed
WO-2005019163-A2 ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS OF SYNTHESIS AND USE XENOPORT, INC. (US) 2005-03-03 WO disclosed
US-6706916-B1 ESTERIFICATION OF OPTICALLY-ACTIVE AMINO ACIDS WITH BENZYL ALCOHOLS IN HYDRAZINE PRESENCE TORAY FINE CHEMICALS CO., LTD. (JP) 2004-03-16 US disclosed
EP-1156032-A1 OPTICALLY ACTIVE AMINO ACID DERIVATIVES AND PROCESSES FOR THE PREPARATION OF THE SAME TORAY INDUSTRIES, INC. (JP) 2001-11-21 EP disclosed
EP-0600714-B1 Process for producing O,O'-diacyltartaric anhydride and process for producing O,O'-diacyltartaric acid TORAY INDUSTRIES (JP) 1999-08-18 EP disclosed
EP-0924188-A1 Production of 0,0'-diacyltartaric acid crystals TORAY INDUSTRIES, INC. (JP) 1999-06-23 EP disclosed
US-5512581-A ANTIINFLAMMATORY AGENT ABBOTT LABORATORIES (US) 1996-04-30 US disclosed
US-5451687-A Process for producing O,O'-diacyltartaric anhydride and process for producing O,O'-diacyltartaric acid TORAY INDUSTRIES, INC. (JP) 1995-09-19 US disclosed
EP-0600714-A1 Process for producing O,O'-diacyltartaric anhydride and process for producing O,O'-diacyltartaric acid TORAY INDUSTRIES, INC. (JP) 1994-06-08 EP disclosed
US-5198449-A N-substituted alpha-arylazacycloalkylmethanamines and their use as cardiovascular agents A. H. ROBINS COMPANY INCORPORATED (US) 1993-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10385014-B2 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use APEH, ABAT, SI LMNA 3875/4885F2 1924/4885PPM1B 2580/4885
US-20180258032-A1 ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS OF SYNTHESIS AND USE APEH, ABAT, SI LMNA 3875/4885F2 1924/4885PPM1B 2580/4885
US-20200087255-A1 METHOD OF PREPARING (3R,4S)-3-ACETAMIDO-4-ALLYL-N-(TERT-BUTYL)PYRROLIDINE-3-CARBOXAMIDE TERT, CTPS1, CTPS2 LMNA 2152/4885F2 3581/4885PPM1B 4240/4885
US-20170190657-A1 ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS OF SYNTHESIS AND USE APEH, ABAT, SI LMNA 3875/4885F2 1924/4885PPM1B 2580/4885
US-10906872-B2 Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide TERT, CTPS1, CTPS2 LMNA 2152/4885F2 3581/4885PPM1B 4240/4885
US-11370754-B2 Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide TERT, CTPS1, CTPS2 LMNA 2152/4885F2 3581/4885PPM1B 4240/4885
US-20050107334-A1 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use APEH, ABAT, SI LMNA 3875/4885F2 1924/4885PPM1B 2580/4885
US-20210155589-A1 METHOD OF PREPARING (3R,4S)-3-ACETAMIDO-4-ALLYL-N-(TERT-BUTYL)PYRROLIDINE-3-CARBOXAMIDE TERT, CTPS1, CTPS2 LMNA 2152/4885F2 3581/4885PPM1B 4240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.